Does ADHD Medication Work?

Plain-language summary

Research suggests that medication can be an effective part of a treatment plan for ADHD in both children and adults, often improving core ADHD symptoms and daily functioning. However, it's important to remember that quality of life improvements can vary, and other approaches, like cognitive behavioral therapy, also show promise, especially for adults.

Key findings

• Medications for ADHD, both in children/adolescents and adults, are often effective in reducing core ADHD symptoms such as inattention, hyperactivity, and impulsivity.
• Research indicates that pharmacological treatments can lead to improvements in daily functioning and overall well-being for individuals with ADHD.
• While medication can help with core ADHD symptoms, its impact on broader quality of life aspects may vary, suggesting that a comprehensive approach is often beneficial.
• For adults with ADHD, cognitive behavioral interventions can be effective in addressing symptoms and improving functioning, extending beyond just the core symptoms of ADHD.
• Evidence regarding the effectiveness of omega-3 fatty acid supplements for ADHD in young people is limited and mixed, suggesting more research is needed to draw firm conclusions.

Studies cited (4)

1. Systematic Review and Meta-Analysis: Effects of Pharmacological Treatment for Attention-Deficit/Hyperactivity Disorder on Quality of Life — Bellato A, Perrott NJ, Marzulli L (2025, Journal of the American Academy of Child and Adolescent Psychiatry, meta-analysis)

   DOI: 10.1016/j.jaac.2024.05.023

2. Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis — Elliott J, Johnston A, Husereau D (2020, PloS one, meta-analysis)

   DOI: 10.1371/journal.pone.0240584 PMCID: PMC7577505

3. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis — Cortese S, Adamo N, Del Giovane C (2018, The lancet. Psychiatry, meta-analysis)

   DOI: 10.1016/S2215-0366(18)30269-4 PMCID: PMC6109107

4. A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder — Nasser A, Hull JT, Chaturvedi SA (2022, CNS drugs, rct)

   DOI: 10.1007/s40263-022-00938-w PMCID: PMC9328182